Searle & Co’s Sanofi SNY Stock Holding History

Searle & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Sell	9,500 -500	-5%	-$22.3K	0.09%	136
2026 Q1	$482K	Hold	10,000	–	–	0.12%	123
2025 Q4	$485K	Hold	10,000	–	–	0.13%	118
2025 Q3	$472K	Buy	+10,000	New	+$483K	0.13%	122
2018 Q2	–	Sell	-26,000	Closed	-$1.04M	–	134
2018 Q1	$1.04M	Sell	26,000 -1,800	-6%	-$74.9K	0.68%	49
2017 Q4	$1.2M	Sell	27,800 -700	-2%	-$32.3K	0.75%	47
2017 Q3	$1.42M	Hold	28,500	–	–	0.94%	39
2017 Q2	$1.36M	Sell	28,500 -200	-0.7%	-$9.56K	0.94%	40
2017 Q1	$1.3M	Hold	28,700	–	–	0.91%	40
2016 Q4	$1.16M	Sell	28,700 -200	-0.7%	-$7.88K	0.96%	37
2016 Q3	$1.11M	Buy	+28,900	New	+$1.16M	0.96%	40
2016 Q2	–	Sell	-28,950	Closed	-$1.17M	–	86
2016 Q1	$1.17M	Sell	28,950 -200	-0.7%	-$8.04K	1.08%	36
2015 Q4	$1.23M	Buy	29,150 +1,425	+5%	+$65.6K	1.18%	31
2015 Q3	$1.32M	Sell	27,725 -1,525	-5%	-$77.7K	1.35%	20
2015 Q2	$1.45M	Hold	29,250	–	–	1.21%	21
2015 Q1	$1.45M	Sell	29,250 -2,050	-7%	-$98K	1.24%	21
2014 Q4	$1.43M	Buy	+31,300	New	+$1.52M	1.21%	19

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Searle & Co's SNY Position: Q2 2026 in Review

Searle & Co reduced its Sanofi (SNY) stake by 5% in Q2 2026, selling an estimated $22.3K and leaving 9,500 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #136.

Searle & Co first reported a position in SNY in Q4 2014 and has held it in 17 quarters since. The position peaked at $1.45M in Q2 2015. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Searle & Co held 9,500 shares of Sanofi worth $405K as of Q2 2026.
Searle & Co sold 500 Sanofi shares in Q2 2026, an estimated $22.3K.
Sanofi made up 0.09% of Searle & Co's portfolio in Q2 2026, its #136 holding.
Searle & Co first reported a position in Sanofi in Q4 2014 and has held it in 17 quarters since.
Searle & Co's Sanofi position peaked at $1.45M in Q2 2015.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.